Ligand Pharmaceuticals OverviewLigand Pharmaceuticals Research & Development
Research & Development expenses for LGND.
Quarterly R&D Expenses
$2.15M
↓ 95.71% YoY
As of Mar 31, 2026
Annual R&D Expenses (TTM)
$33.24M
↓ 49.27% YoY
Trailing 12 months ending Mar 31, 2026